BACK

George W. Sledge, Jr., MD

Executive Vice President and Chief Medical Officer

Dr. George W. Sledge, Jr. joined Caris Life Sciences in October 2022 and serves as Executive Vice President and Chief Medical Officer. In this role, Dr. Sledge has oversight for medical affairs, research, and medical education, including oversight and leadership for the Caris Precision Oncology Alliance, and Caris’ global team of Medical Science Liaisons.

Prior to joining Caris, Dr. Sledge was Professor of Medicine at the Stanford University School of Medicine where he served as a member of the Division of Oncology. He was most recently co-director of the Stanford Cancer Institute’s Cancer Therapeutics Program and served from 2013-2020 as Chief of the Division of Oncology. Trained in Internal Medicine and Medical Oncology, Dr. Sledge has devoted his professional career to understanding the biology and improving the treatment of breast cancer. He is active as both a laboratory and clinical researcher, with more than 390 scientific publications.

Dr. Sledge has held countless esteemed positions including serving as chair of the Eastern Cooperative Oncology Group’s Breast Cancer Committee (2003-2010), a member of the Food and Drug Administration’s Oncology Drug Advisory Committee, a member of the Department of Defense’s Breast Cancer Research Program’s Integration Panel as well as the National Cancer Institute’s Clinical Trials Advisory Board. He is Past President of the American Society of Clinical Oncology, and served as both the Chief Scientific Advisor for the Susan G. Komen Foundation and member of the Triple Negative Breast Cancer Foundation scientific advisory board.

He has received numerous prestigious honors, notably the Breast Cancer Research Foundation’s Jill Rose Award, the Komen Foundation’s Brinker Award for Scientific Distinction, the San Antonio Breast Cancer Symposium’s William L. McGuire Award and the American Society of Clinical Oncology’s Gianni Bonadonna Award.